Literature DB >> 23777685

Establishing a regional network of academic centers to support decision making for new vaccine introduction in Latin America and the Caribbean: the ProVac experience.

C M Toscano1, B Jauregui, C B Janusz, A Sinha, A D Clark, C Sanderson, S Resch, C Ruiz Matus, J K Andrus.   

Abstract

BACKGROUND: The Pan American Health Organization's ProVac Initiative, designed to strengthen national decision making regarding the introduction of new vaccines, was initiated in 2004. Central to realizing ProVac's vision of regional capacity building, the ProVac Network of Centers of Excellence (CoEs) was established in 2010 to provide research support to the ProVac Initiative, leveraging existing capacity at Latin American and Caribbean (LAC) universities. We describe the process of establishing the ProVac Network of CoEs and its initial outcomes and challenges.
METHODS: A survey was sent to academic, not-for-profit institutions in LAC that had recently published work in the areas of clinical decision sciences and health economic analysis. Centers invited to join the Network were selected by an international committee on the basis of the survey results. Selection criteria included academic productivity in immunization-related work, team size and expertise, successful collaboration with governmental agencies and international organizations, and experience in training and education. The Network currently includes five academic institutions across LAC.
RESULTS: Through open dialog and negotiation, specific projects were assigned to centers according to their areas of expertise. Collaboration among centers was highly encouraged. Faculty from ProVac's technical partners were assigned as focal points for each project. The resulting work led to the development and piloting of tools, methodological guides, and training materials that support countries in assessing existing evidence and generating new evidence on vaccine introduction. The evidence generated is shared with country-level decision makers and the scientific community.
CONCLUSIONS: As the ProVac Initiative expands to other regions of the world with support from immunization and public health partners, the establishment of other regional and global networks of CoEs will be critical. The experience of LAC in creating the current network could benefit the formation of similar structures that support evidence-based decisions regarding new public health interventions.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Mesh:

Substances:

Year:  2013        PMID: 23777685     DOI: 10.1016/j.vaccine.2013.05.033

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  6 in total

Review 1.  A systematic review of health economic evaluations of vaccines in Brazil.

Authors:  Ana Marli Christovam Sartori; Luciana Martins Rozman; Tassia Cristina Decimoni; Roseli Leandro; Hillegonda Maria Dutilh Novaes; Patrícia Coelho de Soárez
Journal:  Hum Vaccin Immunother       Date:  2017-01-27       Impact factor: 3.452

2.  Enhancing the work of the Department of Health and Human Services national vaccine program in global immunization: recommendations of the National Vaccine Advisory Committee: approved by the National Vaccine Advisory Committee on September 12, 2013.

Authors: 
Journal:  Public Health Rep       Date:  2014       Impact factor: 2.792

3.  How to Get Cost-Effectiveness Analysis Right? The Case of Vaccine Economics in Latin America.

Authors:  Amanda Glassman; Oscar Cañón; Rachel Silverman
Journal:  Value Health       Date:  2016-12       Impact factor: 5.725

4.  Nutrition modeling tools: a qualitative study of influence on policy decision making and determining factors.

Authors:  Frances Knight; Megan W Bourassa; Elaine Ferguson; Helen Walls; Saskia de Pee; Stephen Vosti; Homero Martinez; Carol Levin; Monica Woldt; Kavita Sethurman; Gilles Bergeron
Journal:  Ann N Y Acad Sci       Date:  2022-04-20       Impact factor: 6.499

5.  Evidence-based decision-making for vaccine introductions: Overview of the ProVac International Working Group's experience.

Authors:  Barbara Jauregui; Ana Gabriela Felix Garcia; Cara Bess Janusz; Julia Blau; Aline Munier; Deborah Atherly; Mercy Mvundura; Rana Hajjeh; Benjamin Lopman; Andrew David Clark; Louise Baxter; Raymond Hutubessy; Ciro de Quadros; Jon Kim Andrus
Journal:  Vaccine       Date:  2015-05-07       Impact factor: 3.641

Review 6.  Introducing a dengue vaccine to Mexico: development of a system for evidence-based public policy recommendations.

Authors:  Miguel Betancourt-Cravioto; Pablo Kuri-Morales; Jesús Felipe González-Roldán; Roberto Tapia-Conyer
Journal:  PLoS Negl Trop Dis       Date:  2014-07-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.